Thompson Juliet 4

What Happened

• Juliet Thompson, a director of Indivior Pharmaceuticals, received a grant of 3,722 Restricted Stock Units (RSUs) on 2026-01-26. The RSUs were granted at $0.00 per unit (no cash paid; reported value $0). Each RSU represents a contingent right to one share of Indivior common stock and will vest the day immediately preceding the date of the first annual meeting of stockholders after the grant, provided Thompson remains in service.

Key Details

• Transaction date: 2026-01-26; Filing date: 2026-01-28 (appears to be timely).
• Grant price: $0.00 per RSU; total reported acquisition value: $0.
• Shares acquired: 3,722 RSUs (each converts to one share upon vesting).
• Shares owned after transaction: Not specified in the Form 4.
• Footnote: F1 — RSUs vest the day before the next annual meeting, contingent on continued service.
• Filing timeliness: Reported two days after the transaction date; no late-filing indication in the report.

Context

• RSU grants are a form of compensation for directors; they are not immediate share purchases or sales. The recipient only receives actual shares if and when the RSUs vest, and the monetary value realized will depend on Indivior’s share price at vesting.
• Such awards are common for non-employee directors and do not by themselves indicate a buy/sell sentiment by the insider.